Paolo Zocca - Publications

Complex all-comers and patients with diabetes and prediabetes treated with Xience Sierra everolimus-eluting stents: COASTLINE high-risk.

Journal: European heart journal open

Published: June 19, 2025

Impact of diabetes on three-year outcome after coronary stenting in patients with polyvascular atherosclerotic disease - a secondary analysis of the randomized TWENTE trials.

Journal: International journal of cardiology. Heart & vasculature

Published: February 14, 2025

Preferred Treatment and Expected Risk in Coronary Intervention Patients With Peripheral Arterial Disease: Cardiologists' Views Versus Trials Data.

Journal: CJC open

Published: February 01, 2025

Sex and age-specific 10-year mortality after coronary stenting: an analysis of two randomized trials.

Journal: European heart journal open

Published: November 14, 2024

Treatment of in-stent restenosis with ultrathin-strut versus thin-strut drug-eluting stents or drug-eluting balloons: a multicentre registry.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: November 04, 2024

Cost-Effectiveness of Three Different New-Generation Drug-Eluting Stents in the Randomised BIO-RESORT Trial at 3 Years.

Journal: PharmacoEconomics - open

Published: October 06, 2024

Final 5-year report of BIONYX comparing the thin-composite wire-strut zotarolimus-eluting stent versus ultrathin-strut sirolimus-eluting stent.

Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Published: April 11, 2024

Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: April 11, 2024

Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease.

Journal: Atherosclerosis

Published: November 24, 2023

Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention.

Journal: Frontiers in cardiovascular medicine

Published: February 06, 2023

Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.

Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Published: January 19, 2023

Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials.

Journal: Cardiovascular diagnosis and therapy

Published: December 12, 2022